scholarly article | Q13442814 |
P356 | DOI | 10.1002/1097-0142(196901)23:1<64::AID-CNCR2820230107>3.0.CO;2-M |
P698 | PubMed publication ID | 4178827 |
P50 | author | Eva Maria Fenyö | Q89369110 |
P2093 | author name string | Clifford P | |
Klein E | |||
Nadkarni JJ | |||
Nadkarni JS | |||
Manolov G | |||
P2860 | cites work | Preliminary observations on new lymphoblast strains (EB4, EB5) from Burkitt tumours in a British and a Ugandan patient | Q36036780 |
Kinetics and chromosome analyses of tissue culture lines derived from Burkitt lymphomata | Q36036958 | ||
THE BEHAVIOUR AND MORPHOLOGY OF A SECOND TISSUE CULTURE STRAIN (EB2) OF LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. | Q36127751 | ||
Evidence for anti-Burkitt tumour globulins in Burkitt tumour patients and healthy individuals | Q41403650 | ||
Cytogenetic and other studies on the EB4 line of Burkitt tumour cells | Q41407824 | ||
P4510 | describes a project that uses | Daudi | Q54828579 |
Esther | Q54832838 | ||
Issac IV | Q54898328 | ||
Margret | Q54904029 | ||
Silfere | Q54953491 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell line | Q21014462 |
Burkitt lymphoma | Q1016605 | ||
P304 | page(s) | 64-79 | |
P577 | publication date | 1969-01-01 | |
P1433 | published in | Cancer | Q326041 |
P1476 | title | Characteristics of new cell lines derived from Burkitt lymphomas | |
P478 | volume | 23 |
Q30907982 | A comparison between protein profiles of B cell subpopulations and mantle cell lymphoma cells |
Q39964294 | Absence of infectious Epstein–Barr virus in blood in acute infectious mononucleosis |
Q40185728 | Activation of latent Epstein–Barr virus by antibody to human IgM |
Q45797418 | Analysis of transformation with epstein-barr virus and phenotypic characteristics of lymphoblastoid cell lines established from patients with hairy cell leukemia |
Q39892628 | Aspects of the EB virus. |
Q42550049 | Base-pair resolution DNA methylome of the EBV-positive Endemic Burkitt lymphoma cell line DAUDI determined by SOLiD bisulfite-sequencing. |
Q70106592 | Biologic and pharmacologic effects of harringtonine on human leukemia-lymphoma cells |
Q40282200 | Burkitt's lymphoma cells: Membrane properties and surface morphology as seen by scanning electron microscopy |
Q46866949 | Burkitt's lymphoma with female karyotype in an African male child |
Q69144763 | Burkitt's lymphoma: a B or T cell tumour? |
Q36271630 | Cell surface immunoglobulin. 3. Isolation and characterization of immunoglobulin from nonsecretory human lymphoid cells |
Q53890334 | Characteristics of Herpesvirus saimiri-induced lymphoma cells in tissue culture. |
Q39928173 | Characteristics of cell lines derived from human leukocytes transformed by different strains of epstein-barr virus |
Q41691384 | Characterization of a newly established human burkitt's lymphoma cell line, OMA-BL-1 |
Q39620183 | Chromosomal Abnormalities and Their Specificity in Human Neoplasms: An Assessment of Recent Observations by Banding Techniques |
Q36412966 | Classification and biological nature of established human hematopoietic cell lines |
Q40078492 | Comparative studies on adult donor lymphocytes infected by EB virusin vivo orin vitro: Origin of transformed cells arising in co-cultures with foetal lymphocytes |
Q69913199 | Comparison of the anti-ebv titer and the ebv-associated membrane reactive and precipitating antibody levels in the sera of burkitt lymphoma and nasopharyngeal carcinoma patients and controls |
Q34476379 | Complement-Fixing Antigens in Lymphoid Cell Lines of American Origin |
Q37134289 | Complement-fixation test for detection of herpes-like viruses in cell cultures of Burkitt's lymphoma |
Q34172407 | Complement-fixing antigens in Burkitt lymphoma cell lines |
Q39871271 | Cultivation with K562 cells leads to blastogenesis and increased cytotoxicity with changed properties of the active cells when compared to fresh lymphocytes |
Q41632386 | Different localization of Epstein-Barr virus genome in two subclones of the Burkitt lymphoma cell line Namalwa. |
Q47778674 | Direct membrane fluorescence reaction of EBV-carrying human lymphoblastoid cells: Blocking tests with xenogeneic antisera |
Q38363171 | Distinct patterns of mitogen-activated protein kinase phosphorylation and Epstein-Barr virus gene expression in Burkitt's lymphoma cell lines versus B lymphoblastoid cell lines |
Q69914330 | Effect of metabolic inhibitors on membrane immunofluorescence reactivity of established burkitt lymphoma cell lines |
Q40191183 | Electron microscopic studies of tumor viruses. II. Entry and uncoating of Epstein-Barr virus |
Q40136771 | Epstein-Barr virus (EBV), lymphocytes and transformation |
Q45799776 | Epstein-Barr virus (EBV)--lymphoid cell interactions. II. The influence of the EBV replication cycle on natural killing and antibody-dependent cellular cytotoxicity against EBV-infected cells. |
Q45821096 | Epstein-Barr virus (EBV)-associated antibody patterns in malignant lymphoma and leukemia. II. Chronic lymphocytic leukemia and lymphocytic lymphoma |
Q39920743 | Epstein-Barr virus binding sites on lymphocyte subpopulations and the origin of lymphoblasts in cultured lymphoid cell lines and in the blood of patients with infectious mononucleosis |
Q45822159 | Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients |
Q29619570 | Establishment and characterization of a human histiocytic lymphoma cell line (U-937) |
Q93699966 | Foreign-cell contamination in Burkitt tumours |
Q30442769 | Immunoglobulin and glucose-6-phosphate dehydrogenase as markers of cellular origin in Burkitt lymphoma |
Q36270839 | Immunoglobulin synthesis and secretion. VI. Synthesis and intracellular transport of immunoglobulin in nonsecretory lymphoma cells |
Q47766047 | Increase in antibody titer against the EBV-associated membrane antigen complex in Burkitt's lymphoma and nasopharyngeal carcinoma after local irradiation |
Q38355201 | Inducing the loss of immunoglobulin lambda light chain production and the rearrangement of a previously excluded allele in human plasma B cell lines with concanavalin A. |
Q40145159 | Lymphoblastoid cell lines from sarcoid patients |
Q45821891 | Lymphoid cell lines: activation of a latent herpes-like virus particle? |
Q37331424 | Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution |
Q40814255 | MedB-1, a human tumor cell line derived from a primary mediastinal large B-cell lymphoma |
Q40119538 | Non-random chromosome gains in human lymphoblastoid cell lines |
Q39962697 | Origin of lymphoid lines established from mixed cultures of cord-blood lymphocytes and explants from infectious mononucleosis, burkitt lymphoma and healthy donors |
Q40135384 | Phenotypic and Cytogenetic Characteristics of Human B-Lymphoid Cell Lines and Their Relevance for the Etiology of Burkitt'S Lymphoma |
Q45796402 | Plasmodium falciparum products enhance human lymphocyte transformation by Epstein-Barr virus |
Q45801409 | Re-evaluation of a transforming strain of epstein-barr virus from the burkitt lymphoma cell line, Jijoye |
Q36791097 | Recent studies with EB virus |
Q34072709 | Receptors for complement and immunoglobulin on human leukemic cells and human lymphoblastoid cell lines |
Q53877549 | Rosette formation of human erythrocytes on cultured cells of tumour origin and activation of complement by cell membrane |
Q67261618 | Solubilization of IgM-kappa specific surface material from Burkitt lymphoma cell lines |
Q47778661 | Some factors affecting membrane immunofluorescence reactivity of burkitt lymphoma tissue culture cell lines |
Q72654354 | Staphylococcal protein a enhances natural killing activity against lymphoid tumor cell lines |
Q52829915 | Surface antigens on lymphoblastoid cells derived from nasopharyngeal carcinoma. |
Q43678747 | Synthesis and intracellular transport of immunoglobulin in secretory and nonsecretory cells |
Q43421521 | Synthesis of immunoglobulins by biopsied tissues and cell lines from Burkitt's lymphoma |
Q40127488 | The Relative Role of Viral Transformation and Specific Cytogenetic Changes in the Development of Murine and Human Lymphomas |
Q53719651 | The chromosomes of an in vitro derivative of an Ehrlich ascites tumor of the mouse during its adaptation from monolayer to suspension culture |
Q40770329 | The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease |
Q39140286 | Tumorigenicity of human hematopoietic cell lines in athymic nude mice |
Q39955407 | Use Of Genetic Markers To Study Cellular Origin And Development Of Tumors In Human Females |
Q58975241 | Xenotransplantation of a Burkitt Lymphoma Culture Line with Surface Immunoglobulin Specificity |
Q67246884 | [Macroglobulin-producing chronic lymphocytic leukemia without macroglobulinemia] |
Search more.